> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bryant Ranch Recalls Mislabeled Spironolactone
- URL: https://www.fdaweb.com/bryant-ranch-recalls-mislabeled-spironolactone/
- Published: 2021-03-10T12:00:00.000Z
- Updated: 2026-09-14T16:50:16.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148849

Bryant Ranch Prepack has recalled four lots of spironolactone tablets after determining they have been mislabeled and display the incorrect strength. “Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets and prepackaged bottles of spironolactone 25 mg may contain spironolactone 50 mg tablets,” a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bryant-ranch-prepack-issues-voluntary-nationwide-recall-spironolactone-25-mg-and-50-mg-tablets-due?ref=fdaweb.com) says. Spironolactone is indicated as a diuretic for treating high blood pressure, heart failure, hypokalemia, and edema and is repackaged in 30, 60 and 90-count bottles, the notice says.